Dosimetric and physical comparison of IMRT and CyberKnife plans in the treatment of localized prostate cancer

Reports of Practical Oncology and Radiotherapy

Volumn 15, Issue 6, 2010, Pages 181-189

  Ceylan, Cemile ^a   Kucuk, Nadir ^a   Bas Ayata, Hande ^a   Guden, Metin ^a   Engin, Kayihan ^a  

^a Anadolu Medical Center   (Turkey)

Author keywords

CyberKnife; IMRT; Prostate; Radiosurgery

Indexed keywords

AGED; ARTICLE; BLADDER; CLINICAL ARTICLE; CYBERKNIFE; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; PROSTATE CANCER; RADIATION DOSE; RECTUM; TREATMENT PLANNING; TUMOR VOLUME;

EID: 78649785220     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2010.10.003     Document Type: Article

References (30)

1. Ashman Jonathan B., Zelefsky Micheal J., Hunt Margie S., Leibel Steven A., Fuks Zvi Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63(3):765-771.
2. Luxton Gary, Hancock Steven L., Boyer Arthur L. Dosimetry and radiobiological model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2004, 59(1):267-284.
3. Vlachaki Maria T., Teslow Terrance N., Amosson Chad, Uy Nathan W., Ahmad Salahuddin IMRT versus conventional 3DCRT on prostate and normal tissue dosimetry using an endorectal balloon for prostate immobilization. Med Dosim 2005, 30(2):69-75.
4. James H.V., Scrase C.D., Poynter A.J. Practical experience with intensity-modulated radiotherapy. Br J Radiol 2004, 77:3-14.
5. Kara Bucci M., Bevan Alison, Roach Mack Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin 2005, 55:117-134.
6. van de Bunt Linda, Van der Heide Uulke A., Ketelaars Martijn, de Kort Gerard A.P., Jürgenliemk-Schulz Ina M. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: the impact of tumor regression. Int J Radiat Oncol Biol Phys 2006, 64(1):189-196.
7. De Meerleer Gert, Vakaet Luc, Meersschout Sabine, Villeirs Gert, Verbaeys Antony, Oosterlinck Wim, et al. Intensity modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. Int J Radiat Oncol Biol Phys 2004, 60(3):777-787.
8. De Meerleer Gert, Vakaet Luc, De Gersem Werner R.T., De Wagter Carlos, De Naeyer Bart, De Neve Wilfried Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int J Radiat Oncol Biol Phys 2000, 47(3):639-648.
9. Sethi Anil, Mohideen Najeeb, Leybovich Leonid, Mulhall John Role of IMRT in reducing doses in dose escalation for prostate cancer. Int J Radiat Oncol Biol Phys 2003, 55(4):970-978.
10. Zelefsky Micheal J., Fuks Zvi, Happertsett Laura, Lee Henry J., Ling C.Clifton, Burman Chandra M., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiat Oncol 2000, 5:241-249.
11. Ezzell Gary A., Galvin James M., Low Daniel, Palta Jatinder R., Rosen Isaac, Sharpe Michael B., et al. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT subcommittee of the AAPM radiation therapy committee. Med Phys 2003, 30(8):2089-2115.
12. Boehmer Dirk, Maingon Philippe, Poortmans Philip, Baron Marie-Hélène, Miralbell Raymond, Remouchamps Vincent, et al. Guidelines for primary radiotherapy of patients with prostate cancer. Radiat Oncol 2006, 79:259-269.
13. Jones Andrew O., Kleiman Marc T. Patient setup and verification for intensity-modulated radiation therapy (IMRT). Med Dosim 2003, 28(3):175-183.
14. Nederveen A.J., van der Heide U.A., Dehnad H., van Moorselaar R.J., Hofman P., Lagendijk J.J. Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int J Radiat Oncol Biol Phys 2002, 53:206-214.
15. Aubin M, Liu Y, Langen KM, Shinohara Katsuto, Anezinos Chris, Osofsky Melanie, et al. Set-up verification using portal images of implanted markers: an inter-observer study. In Abstract 44th annual ASTRO meeting, 2002.
16. Brenner David J. Hypofractionation for prostate cancer radiotherapy-What are the issues?. Int J Radiat Oncol Biol Phys 2003, 57(4):912-914.
17. Fowler F., Ritter M.A., Chappell R.J., Brenner David J. What hypofractionated protocols should be tested for prostate cancer?. Int J Radiat Oncol Biol Phys 2003, 56:1093-2003.
18. Galvin James M., Ezzell Garyy, Eisbrauch Avraham, Yu Cedric, Butler Brian, Xiao Ying, et al. Implementing IMRT in clinical practice: a joint document of the American society for therapeutic radiology and oncology and the American association of physicists in medicine. Int J Radiat Oncol Biol Phys 2004, 58(5):1616-1634.
19. Carlo Cavedon, Joseph Stancanello, Paolo Francescon, Stefania Cora, Paolo Scalchi, Emanuela Berna, et al. Spelized imaging techniques for cyberknife treatment planning. In Robotic radiosurgery, vol. 1; 2005. p. 81-94 [chapter 9].
20. Pollack Alan, Zagars Gunar, Starkschall Gergo, Antolak John A., Lee J.Jack, Huang Eugene, et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002, 53(5):1097-1105.
21. Zelefsky Micheal J., Fuks Zvi, Hunt Margie, Yamada Yoshiya, Marion Christine, Ling C.Clifton, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002, 53(5):1111-1116.
22. Adams Elizabeth J., Convery David J., Cosgrove Vivian P., McNair Helen A., Staffurth John N., Vaarkamp Jaap, et al. Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement. Radiat Oncol 2004, 70:1-10.
23. Livi Lorenzo, Paiar Fabiola, Banci-Buonamici Fabrizio, Gabriele Simontacchi, Beatrice Detti, Mauro Gacci, et al. Localized prostate cancer treated with intensity-modulated radiotherapy. Tumori 2006, 92:201-206.
24. Melian Edward, Mageras Gig S., Fuks Zvi, Leibel Steven A., Niehaus Anita, Lorant Helen, et al. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys 1997, 38(1):73-81.
25. Wu Vincent W.C., Kwong Dora L.W., Sham Jonathan S.T. Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiat Oncol 2004, 71:201-206.
26. Feuvret Loic, Noel Georges, Mazeron Jean-Jacques, Bey Pierre Conformity index: a review. Int J Radiat Oncol Biol Phys 2006, 64(2):333-342.
27. Teh Bin S., Bastach Micheal D., Wheeler Thomas M., Maiet Wei-Yuan, Frolov Anna, Uhl Barry M., et al. IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease. Int J Radiat Oncol Biol Phys 2003, 56(1):184-191.
28. Brenner David J., Hall Eric J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999, 43(5):1095-1101.
29. Bindhu J., Supe Sanjay S., Ramachandra Aruna Cyberknife: a double edged sword?. Rep Pract Oncol Radiother 2010, 15(4):93-97.
30. Soete G., Arcangeli S., De Meerleer G., Landoni V., Fonteyne V., Arcangeli G., et al. Phase II study of a four-week hypofractioned external beam radiotherapy regimen for prostate cancer: report on acute toxicity. Radiother Oncol 2006, 80:78-81.